Literature DB >> 1666914

PET studies in the primate brain and biodistribution in mice using (-)-5'-18F-delta 8-THC.

A Charalambous1, G Marciniak, C Y Shiue, S L Dewey, D J Schlyer, A P Wolf, A Makriyannis.   

Abstract

Cannabinoids, the active constituents of marijuana, are known to have many therapeutic properties; however, their exact mechanism of action is not well understood. In an effort to obtain more information concerning the pharmacokinetics and biodistribution of psychoactive THC analogs we synthesized (-)-18F-delta 8-THC and studied its biodistribution in mice and baboon brains. The analog was obtained by nucleophilic fluorination of the ditriflate ester of (-)-5'-OH-delta 8-THC with K18F/Kryptofix followed by deprotection with LiAIH4 and purification with HPLC in 8% yield in a 90-min synthesis from EOB. The uptake of (-)-5'-18F-delta 8-THC in mouse tissue was high at 5 min, but radioactivity declined rapidly in almost all the tissues studied. Following IV administration, (-)-5'-18F-delta 8-THC uptake in baboon brain was similar in the basal ganglia, thalamus and cerebellum, and the clearance from these regions was relatively rapid. Also, a study from baboon plasma clearance of (-)-5'-18F-delta 8-THC showed rapid metabolism of the analog.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666914     DOI: 10.1016/0091-3057(91)90354-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.

Authors:  Peter J Crocker; Anu Mahadevan; Jenny L Wiley; Billy R Martin; Raj K Razdan
Journal:  Bioorg Med Chem Lett       Date:  2007-01-13       Impact factor: 2.823

2.  The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.

Authors:  Iram P Rodriguez-Sanchez; Josee Guindon; Marco Ruiz; M Elizabeth Tejero; Gene Hubbard; Laura E Martinez-de-Villarreal; Hugo A Barrera-Saldaña; Edward J Dick; Anthony G Comuzzie; Natalia E Schlabritz-Loutsevitch
Journal:  Neurotoxicol Teratol       Date:  2016-06-18       Impact factor: 3.763

3.  The role of halogen substitution in classical cannabinoids: a CB1 pharmacophore model.

Authors:  Spyros P Nikas; Jolanta Grzybowska; Demetris P Papahatjis; Avgui Charalambous; Ali R Banijamali; Ravi Chari; Pusheng Fan; Therapia Kourouli; Sonyuan Lin; Albert J Nitowski; Gilbert Marciniak; Yan Guo; Xiuyan Li; Chia-Lin J Wang; Alexandros Makriyannis
Journal:  AAPS J       Date:  2004-10-19       Impact factor: 4.009

4.  Preclinical evaluation and quantification of [¹⁸F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain.

Authors:  Cindy Casteels; Michel Koole; Sofie Celen; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

5.  Combined and independent effects of chronic marijuana use and HIV on brain metabolites.

Authors:  L Chang; C Cloak; R Yakupov; T Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

6.  Synthesis, Radioiodination and Biodistribution Evaluation of 5-(2-amimo-4-styryl pyrimidine-4-yl)-4-methoxybenzofuran-6-ol.

Authors:  Atteyat A Labib
Journal:  Asia Ocean J Nucl Med Biol       Date:  2013

Review 7.  Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination.

Authors:  Lorenzo Cavina; Dion van der Born; Peter H M Klaren; Martin C Feiters; Otto C Boerman; Floris P J T Rutjes
Journal:  European J Org Chem       Date:  2017-04-26

8.  Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.

Authors:  Daniela A Riaño Barros; Colm J McGinnity; Lula Rosso; Rolf A Heckemann; Oliver D Howes; David J Brooks; John S Duncan; Federico E Turkheimer; Matthias J Koepp; Alexander Hammers
Journal:  Neuroimage       Date:  2014-04-13       Impact factor: 6.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.